arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

COMPASS Pathways plc

CMPS
$14.78 ▼ -0.22 (-1.47%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
27 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Bullish
auto_awesome

Analytical Summary

COMPASS Pathways plc shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.0B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -38.8%
FCF / Share $-0.30
Trailing P/E
Price / Book 23.7x
FCF Yield
Debt / Equity 0.60
info Valuation on last close. End-of-day price, Sep 22, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$91.20M
— 0.0%
FCF / Share Free cash flow per share
$-0.30
↑ +31.5%
Long-Term Debt Long-term obligations
$50.73M
— +0.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health
60
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 27 quarters